Adequate nephroprotection reduces renal complications after hyperthermic intrathoracic chemotherapy

URN to cite this document:: urn:nbn:de:bvb:355-epub-454145
DOI to cite this document:: 10.5283/epub.45414

Markowiak, Till Marvin ; Kerner, Nadine ; Neu, Reiner ; Potzger, Tobias ; Großer, Christian ; Zeman, Florian ; Hofmann, Hans‐Stefan ; Ried, Michael

Preview

License: Creative Commons: Attribution 3.0
PDF - Published Version
(532kB)

Date of publication of this fulltext: 31 Mar 2021 15:33

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Wiley.

Details

Preview

Indexed in

Export bibliographical data

Abstract

Background and Objectives Hyperthermic intrathoracic chemotherapy (HITOC) is used for the treatment of malignant pleural tumors. Although HITOC proved to be safe, postoperative renal failure due to nephrotoxicity of intrapleural cisplatin remains a concern. Methods This single-center study was performed retrospectively in patients who underwent pleural tumor resection and HITOC between September ...